| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Piperacillin sodium |
Is a |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
| Piperacillin measurement |
Component |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
| Piperacillin poisoning |
Causative agent (attribute) |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
| Accidental piperacillin poisoning |
Causative agent (attribute) |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
| Intentional piperacillin poisoning |
Causative agent (attribute) |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
| intoxication par la pipéracilline d'intention indéterminée |
Causative agent (attribute) |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
| Piperacillin adverse reaction |
Causative agent (attribute) |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
| Allergy to piperacillin |
Causative agent (attribute) |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
| pipéracilline 1 g, fiole de poudre pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
| pipéracilline 2 g, fiole de poudre pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
| pipéracilline 4 g, fiole de poudre pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
| Piperacillin with tazobactam |
Is a |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
| Piperacillin 40g injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
| Product containing piperacillin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
| Piperacillin and tazobactam adverse reaction |
Causative agent (attribute) |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
| pipéracilline 4 g/tazobactam 500 mg, fiole de poudre et solvant pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
| Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
| Piperacillin with tazobactam |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
| Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
| Piperacillin+tazobactam 36g/4.5g injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
| Piperacillin sodium ns/tazobactam sodium ns injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
| Product containing piperacillin and tazobactam (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
| Accidental piperacillin poisoning |
Causative agent (attribute) |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
| Intentional piperacillin poisoning |
Causative agent (attribute) |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
| Allergy to piperacillin and tazobactam |
Causative agent (attribute) |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
| Allergy to piperacillin |
Causative agent (attribute) |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
| Allergy to piperacillin and tazobactam |
Causative agent (attribute) |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
| Allergy to piperacillin and tazobactam |
Causative agent (attribute) |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
3 |
| Allergy to piperacillin and tazobactam |
Causative agent (attribute) |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
2 |
| Piperacillin and tazobactam |
Is a |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
| Piperacillin and tazobactam |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
| Piperacillin sodium |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
|
| Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
| Piperacillin- and tazobactam-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
| Piperacillin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
| Piperacillin and tazobactam only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only piperacillin and tazobactam in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
| Piperacillin anhydrous |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
|
| Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only piperacillin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
| Product containing piperacillin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
| Piperacillin and tazobactam desensitisation therapy |
Using substance (attribute) |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
3 |
| Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely piperacillin (as piperacillin sodium) 2 gram and tazobactam (as tazobactam sodium) 250 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely piperacillin (as piperacillin sodium) 2 gram and tazobactam (as tazobactam sodium) 250 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
| Piperacillin (as piperacillin sodium) 4 g and tazobactam (as tazobactam sodium) 500 mg powder for solution for infusion and/or injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
| Piperacillin therapy |
Direct substance |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]